Literature DB >> 8176468

Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.

K Ozker1, C Onsel, L Kabasakal, H B Sayman, I Uslu, S Bozluolçay, T Cansiz, T Kapicioğlu, I Urgancioğlu.   

Abstract

UNLABELLED: Technetium-99m-labeled N,N-ethylenedicysteine (99mTc-EC) is a new renal imaging agent introduced as an alternative for 99mTc-labeled mercaptoacetyltriglycine (99mTc-MAG3), with similar renal excretion characteristics. To evaluate the diagnostic characteristics of this agent, a gamma camera study was performed.
METHODS: Sixteen patients with obstructive renal disease and six normal controls were injected with 90 to 110 MBq of 99mTc-EC and 7.4 MBq 131I-labeled orthoiodohippurate (OIH). Serial images were obtained during 20 min for 99mTc-EC and 30 min for OIH. The study was repeated using 90 to 110 MBq 99mTc-MAG3 during the same week.
RESULTS: Renograms, functional ratios and urinary excretion patterns of all three agents were similar. The mean time to peak activity values for OIH, 99mTc-EC and 99mTc-MAG3 were 4.25 +/- 0.37 min, 4.39 +/- 0.32 min and 4.00 +/- 0.24 min, respectively. The time from peak to 50% activity values for OIH, 99mTc-EC and 99mTc-MAG3 were 5.48 +/- 0.80 min, 6.93 +/- 0.69 min and 7.33 +/- 0.85 min, respectively.
CONCLUSION: It is concluded that 99mTc-EC has excellent imaging characteristics and similar excretion properties to OIH. The advantages of 99mTc-EC over 99mTc-MAG3 are lower hepatobiliary uptake and simplicity of preparation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8176468

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

1.  SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults With Suspected Upper Urinary Tract Obstruction 1.0.

Authors:  Andrew T Taylor; David C Brandon; Diego de Palma; M Donald Blaufox; Emmanuel Durand; Belkis Erbas; Sandra F Grant; Andrew J W Hilson; Anni Morsing
Journal:  Semin Nucl Med       Date:  2018-03-16       Impact factor: 4.446

2.  Technetium-99m-L,L-ethylenedicysteine scintigraphy in patients with renal disorders.

Authors:  N K Gupta; J B Bomanji; W Waddington; D Lui; D C Costa; A M Verbruggen; P J Ell
Journal:  Eur J Nucl Med       Date:  1995-07

3.  Vicarious liver visualization in solitary functioning kidney with technetium-99m ethylenedicysteine renal scintigraphy.

Authors:  Tarun Kumar Jain; Rohit Kumar Phulsunga; Nitin Gupta; Ashwani Sood; Anish Bhattacharya; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2015 Jul-Sep

4.  Assessment of renal function in mice with unilateral ureteral obstruction using 99mTc-MAG3 dynamic scintigraphy.

Authors:  Mohammed N Tantawy; Rosie Jiang; Feng Wang; Keiko Takahashi; Todd E Peterson; Dana Zemel; Chuan-Ming Hao; Hiroki Fujita; Raymond C Harris; Christopher C Quarles; Takamune Takahashi
Journal:  BMC Nephrol       Date:  2012-12-10       Impact factor: 2.388

5.  Differential uptake of Tc-99m DMSA and Tc-99m EC in renal tubular disorders: Report of two cases and review of the literature.

Authors:  Arun Kumar Reddy Gorla; Kanhaiyalal Agrawal; Ashwani Sood; Anish Bhattacharya; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2014-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.